These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 8333890)

  • 1. [Risk of hepatitis B virus transmission by highly viremic chronic carriers in schools].
    Repp R; Seuchter C; Breitbach B; Lampert F; Gerlich WH
    Zentralbl Hyg Umweltmed; 1993 Feb; 194(1-2):126-33. PubMed ID: 8333890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perinatal and intrafamily transmission of hepatitis B virus in three generations of a low-prevalence population.
    Ordög K; Szendrôi A; Szarka K; Kugler Z; Csire M; Kapusinszky B; Xie J; Csizmadia K; Brojnás J; Rusvai E; Tempfli A; Berencsi G
    J Med Virol; 2003 Jun; 70(2):194-204. PubMed ID: 12696105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotype, phylogenetic analysis, and transmission pattern of occult hepatitis B virus (HBV) infection in families of asymptomatic HBsAg carriers.
    Datta S; Banerjee A; Chandra PK; Chowdhury A; Chakravarty R
    J Med Virol; 2006 Jan; 78(1):53-9. PubMed ID: 16299727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver function and hepatitis markers in carriers of hepatitis B virus in New Zealand.
    Hopkirk N; Moyes CD; Lucas CR
    N Z Med J; 2000 Apr; 113(1107):114-6. PubMed ID: 10834277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrafamilial transmission of hepatitis B in Tuzla region of Bosnia and Herzegovina.
    Salkic NN; Zildzic M; Muminhodzic K; Pavlovic-Calic N; Zerem E; Ahmetagic S; Mott-Divkovic S; Alibegovic E
    Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):113-8. PubMed ID: 17272995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
    Sayan M; Mutlu B; Erdoğan S; Meriç M; Willke A
    Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus DNA in relation to duration of hepatitis B surface antigen carriage.
    Mendy ME; Fortuin M; Hall AJ; Jack AD; Whittle HC
    Br J Biomed Sci; 1999; 56(1):34-8. PubMed ID: 10492913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study.
    Amini S; Mahmoodi MF; Andalibi S; Solati AA
    J Trop Med Hyg; 1993 Oct; 96(5):277-87. PubMed ID: 8411302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low level hepatitis B viremia detected by polymerase chain reaction accompanies the absence of HBe antigenemia and hepatitis in hepatitis B virus carriers.
    Niitsuma H; Ishii M; Miura M; Kobayashi K; Toyota T
    Am J Gastroenterol; 1997 Jan; 92(1):119-23. PubMed ID: 8995950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low HBV-DNA levels in end-stage renal disease patients with HBeAg-negative chronic hepatitis B.
    Moutinho RS; Perez RM; Medina-Pestana JO; Figueiredo MS; Koide S; Alberto FL; Silva AE; Ferraz ML
    J Med Virol; 2006 Oct; 78(10):1284-8. PubMed ID: 16927290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epidemiologic significance of persistent observation of serum HBV-DNA in asymptomatic HBsAg carriers].
    Zeng JP
    Zhonghua Liu Xing Bing Xue Za Zhi; 1989 Dec; 10(6):328-30. PubMed ID: 2624930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of precore mutants in anti-HBe-positive hepatitis B virus carriers in Germany.
    Knöll A; Rohrhofer A; Kochanowski B; Wurm EM; Jilg W
    J Med Virol; 1999 Sep; 59(1):14-8. PubMed ID: 10440802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatopathy and hepatitis B virus infection in dialysis patients: cross-sectional study].
    Fabrizi F; Bisegna S; Mangano S; Alongi G; Colucci P; Finazzi S; De Vecchi AF; Ponticelli C
    G Ital Nefrol; 2002; 19(2):149-54. PubMed ID: 12195413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occult hepatitis B virus infection: implications in transfusion.
    Allain JP
    Vox Sang; 2004 Feb; 86(2):83-91. PubMed ID: 15023176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B].
    Altindiş M; Uslan I; Cetinkaya Z; Yüksel S; Ciftçi IH; Demirtürk N; Ozdemir M; Arslan F; Aktepe OC
    Mikrobiyol Bul; 2007 Apr; 41(2):227-33. PubMed ID: 17682709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A revised method for estimating hepatitis B virus transfusion residual risk based on antibody to hepatitis B core antigen incident cases.
    Laperche S; Maniez M; Barlet V; El Ghouzzi MH; Le Vacon F; Levayer T; Lunel F; Morel P; Mouillot L; Piquet Y; Pillonel J;
    Transfusion; 2008 Nov; 48(11):2308-14. PubMed ID: 18673347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus genotypes and spontaneous hepatitis B e antigen seroconversion in Taiwanese hepatitis B carriers.
    Kao JH; Chen PJ; Lai MY; Chen DS
    J Med Virol; 2004 Mar; 72(3):363-9. PubMed ID: 14748059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum hepatitis B virus DNA: relationship with the e-antigen and anti-e status in chronic carriers.
    Yap SF; Wong NW; Goh KL
    Malays J Pathol; 1994 Jun; 16(1):57-62. PubMed ID: 16329577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of HbsAg and HBV DNA in serum and saliva of HBV carriers.
    Noppornpanth S; Sathirapongsasuti N; Chongsrisawat V; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2000 Jun; 31(2):419-21. PubMed ID: 11127351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B surface antigen, e antigen and HBV DNA in healthy antenatal patients attending Goroka Hospital and their relationship to tattooing practices.
    Spooner V; Richens J; Sanders R
    P N G Med J; 1990 Mar; 33(1):11-5. PubMed ID: 2346045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.